12,855 SPDR S&P Biotech ETF $XBI Shares Acquired by Fifth Third Bancorp

Fifth Third Bancorp boosted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 16.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 90,373 shares of the exchange traded fund’s stock after purchasing an additional 12,855 shares during the quarter. Fifth Third Bancorp’s holdings in SPDR S&P Biotech ETF were worth $14,250,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Axiom Investment Management LLC bought a new stake in SPDR S&P Biotech ETF in the first quarter valued at $26,000. Angeles Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the second quarter worth about $28,000. Root Financial Partners LLC bought a new position in shares of SPDR S&P Biotech ETF during the third quarter worth about $31,000. Signature Equity Partners LLC grew its position in shares of SPDR S&P Biotech ETF by 1,285.7% during the third quarter. Signature Equity Partners LLC now owns 194 shares of the exchange traded fund’s stock worth $31,000 after acquiring an additional 180 shares during the last quarter. Finally, Morling Financial Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF during the second quarter worth about $36,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock traded down $0.65 during trading hours on Friday, reaching $150.55. The stock had a trading volume of 7,642,666 shares, compared to its average volume of 9,161,190. SPDR S&P Biotech ETF has a twelve month low of $111.11 and a twelve month high of $169.89. The firm has a 50-day simple moving average of $154.26 and a 200-day simple moving average of $142.92. The firm has a market capitalization of $10.20 billion, a PE ratio of 20.64 and a beta of 0.87.

SPDR S&P Biotech ETF Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

See Also

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.